Data is not available at this time.
Ascom Holding AG is a Swiss-based provider of healthcare ICT and mobile workflow solutions, operating globally in the medical and enterprise sectors. The company specializes in nurse call systems, clinical workflow software, and mobile communication devices, catering primarily to hospitals, long-term care facilities, and industries like retail and hospitality. Its flagship products, such as teleCARE IP and Telligence, integrate real-time monitoring and response systems, enhancing operational efficiency in healthcare settings. Ascom differentiates itself through a focus on interoperability and workflow orchestration, leveraging its Unite platform to unify disparate systems into a cohesive user experience. The company holds a niche position in the healthcare IT market, competing with larger players by offering tailored, scalable solutions for acute and long-term care environments. Its presence in enterprise sectors further diversifies revenue streams, though healthcare remains its core focus. Ascom’s market position is reinforced by its consultative approach, combining hardware, software, and services to address complex workflow challenges.
Ascom reported revenue of CHF 286.7 million for the period, with net income of CHF 3.7 million, reflecting modest profitability. Diluted EPS stood at CHF 0.10, indicating stable but narrow margins. Operating cash flow of CHF 20 million suggests healthy liquidity generation, though capital expenditures of CHF 4.4 million highlight ongoing investments in product development and infrastructure. The absence of debt strengthens its financial flexibility.
The company’s earnings power is constrained by its niche market focus, with diluted EPS of CHF 0.10 underscoring limited scalability. However, its debt-free balance sheet and positive operating cash flow demonstrate efficient capital management. The beta of 1.12 indicates moderate market sensitivity, aligning with its stable but growth-dependent profile in healthcare IT.
Ascom maintains a robust balance sheet with CHF 18.6 million in cash and no debt, ensuring liquidity for operational needs and strategic initiatives. The lack of leverage reduces financial risk, while consistent operating cash flow supports reinvestment and dividend payments. Its financial health is further underscored by a market capitalization of CHF 118.9 million, reflecting investor confidence in its niche positioning.
Growth is likely driven by demand for digital healthcare solutions, though revenue scalability remains a challenge. The company pays a dividend of CHF 0.10 per share, signaling a commitment to shareholder returns despite modest earnings. Future expansion may hinge on broader adoption of its workflow orchestration platforms and cross-sector diversification.
With a market cap of CHF 118.9 million, Ascom trades at a valuation reflective of its niche market role and steady cash flows. Investors appear to price in moderate growth expectations, balanced by its debt-free structure and dividend yield. The beta of 1.12 suggests alignment with broader market movements.
Ascom’s strategic edge lies in its integrated workflow solutions and healthcare specialization, though competition from larger IT providers poses risks. The outlook is cautiously optimistic, with potential growth tied to healthcare digitization trends. Its debt-free status and cash flow stability provide a foundation for incremental innovation and market expansion.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |